Note: Single-source report; awaiting corroboration.
Clinical research involves studying medical treatments and therapies in people. Clinical trials are research studies in which participants are prospectively assigned to one or more interventions to evaluate effects on health-related biomedical or behavioral outcomes. These interventions can include placebo or other control groups.
Participants may be healthy volunteers, who have no significant health problems, or patient volunteers, who have health issues and participate to help understand, diagnose, treat, or cure their condition.
Clinical trials progress through phases. Phase I trials involve a small group (20–80 people) to evaluate safety and identify side effects. Phase II expands to larger groups (100–300) to determine effectiveness and further assess safety. Phase III involves large groups (1,000–3,000) to confirm effectiveness, monitor side effects, and compare the new intervention with standard treatments. Phase IV occurs after FDA approval to track safety and gather more information on risks, benefits, and optimal use.
Study designs often include placebos, substances that look like the new treatment but have no active therapeutic value. Randomization assigns treatments by chance to reduce bias. Single- or double-blind studies are used so participants and sometimes researchers do not know which treatment is administered, ensuring objectivity.
A protocol is a detailed plan that safeguards participants' health and addresses specific research questions. Informed consent is essential, explaining risks and benefits to participants before enrollment. The Principal Investigator, usually a doctor, leads the research team and monitors participants to ensure safety and evaluate effectiveness.